NVR BCR (Tasigna 150 mg)
Generic Name: nilotinib
Pill imprint NVR BCR has been identified as Tasigna 150 mg.
Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for NVR BCR (Tasigna 150 mg)
- Generic Name:
- 150 mg
- Prescription only
- Drug Class:
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
ferric oxide yellow
Tasigna is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...